Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro
Open Access
- 17 November 2021
- journal article
- research article
- Published by Elsevier in STAR Protocols
- Vol. 2 (4) , 100956
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 11 references indexed in Scilit:
- An Improved Protocol for the Production of Lentiviral VectorsSTAR Protocols, 2020
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsNew England Journal of Medicine, 2020
- Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped LentivectorFrontiers in Immunology, 2019
- Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes2016
- Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptorsJournal for ImmunoTherapy of Cancer, 2015
- T cell-NF-κB activation is required for tumor control in vivoJournal for ImmunoTherapy of Cancer, 2015
- Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cellsBMC Biotechnology, 2013
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer CellsPLOS ONE, 2012
- Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage MalignanciesCancer Research, 2011
- Use of Sodium Butyrate to Enhance Production of Retroviral Vectors Expressing CFTR cDNAHuman Gene Therapy, 1995